NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
Neoleukin is a Washington-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer and autoimmune diseases.